Table 1.
Name | Structure | IC50 (μM)a |
|
---|---|---|---|
Peptide cleavage | DUB activity | ||
MERS-CoV PLpro | |||
6-Mercaptopurine (6MP) | 26.9 ± 7.5 | 25.8 ± 5.0 | |
6-Thioguanine (6TG) | 24.4 ± 4.3 | 12.4 ± 1.9 | |
N-ethylmaleimide (NEM) | 45.0 ± 10.1 | NDb | |
Mycophenolic acid | MERS-CoV PLpro | ||
247.6 ± 55.8 | 222.5 ± 57.8 | ||
SARS-CoV PLpro | |||
No inhibition | No inhibition | ||
SARS-CoV PLpro E168R | |||
260.1 ± 21.0 | NDb |
The peptide substrate (Dabcyl–FRLKGGAPIKGV–Edans) at 20 μM or Ub-AFC at 0.5 μM were used for the IC50 assay, respectively. All the assays were repeated several times to ensure reproducibility.
Not determined.